The chief executive officer of Gamida Cell discussed upcoming research on 2 of their investigational agents, GDA-201 and omidubicel, for hematological malignancies.
Julian Adams, PhD
Advertisement
Chief executive officer, Gamida Cell
Articles by Julian Adams, PhD
The chief executive officer of Gamida Cell discussed the company's novel approach to cell proliferation.
Advertisement
Latest Updated Articles
Improving Bone Marrow Transplant With OmidubicelPublished: June 22nd 2021 | Updated:
- Tackling Storage and Logistical Challenges in Cell Therapy
Published: June 24th 2021 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Intellia Puts Phase 3 Trials for Transthyretin Amyloidosis Gene Editing Therapy Nex-Z on Hold Following Grade 4 Liver AE
2
Quarter Century Update: The Continued Unknowns of Cell and Gene Therapy
3
M. Peter Marinkovich, MD, on Integrating Gene Therapy into Clinical Practice for Dermatologists
4
Quarter Century Update: How can Partnerships Between Academia, Biotech, and Pharma be Better Structured?
5
